Illian DN, et al. Current status, distribution, and future directions of natural products against colorectal cancer in Indonesia: a systematic review. Molecules. 2021;26(16):4984.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shaukat A, et al. Endoscopic recognition and management strategies for malignant colorectal polyps: recommendations of the US multi-society task force on colorectal cancer. Gastroenterology. 2020;159(5):1916-1934.e2.
Article
PubMed
Google Scholar
Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology. 2020;158(2):354–67.
Article
PubMed
Google Scholar
Veettil SK, et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw Open. 2021;4(2):e2037341.
Article
PubMed
PubMed Central
Google Scholar
Merchant J, et al. Concepts and prospects of minimally invasive colorectal cancer surgery. Clin Radiol. 2021;76(12):889–95.
Article
CAS
PubMed
Google Scholar
Wu X, et al. Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials. J Gastrointest Surg. 2012;16(3):646–55.
Article
PubMed
Google Scholar
Bregni G, et al. Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev. 2020;83:101948.
Article
CAS
PubMed
Google Scholar
Zhang N, et al. 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules. 2008;13(8):1551–69.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hsu HH, et al. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol. 2018;233(7):5458–67.
Article
CAS
PubMed
Google Scholar
Nikolouzakis TK, et al. Effect of systemic treatment on the micronuclei frequency in the peripheral blood of patients with metastatic colorectal cancer. Oncol Lett. 2019;17(3):2703–12.
CAS
PubMed
PubMed Central
Google Scholar
Turley SJ, Cremasco V, Astarita JL. Immunological hallmarks of stromal cells in the tumour microenvironment. Nat Rev Immunol. 2015;15(11):669–82.
Article
CAS
PubMed
Google Scholar
He Y, et al. Tumor-associated extracellular matrix: how to be a potential aide to anti-tumor immunotherapy? Front Cell Dev Biol. 2021;9:739161.
Article
PubMed
PubMed Central
Google Scholar
Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol. 2018;15(6):366–81.
Article
PubMed
PubMed Central
Google Scholar
Huang P, et al. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater. 2019;85:1–26.
Article
CAS
PubMed
Google Scholar
Pelaz B, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11(3):2313–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oroojalian F, et al. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small. 2021;17(12):e2006484.
Article
PubMed
CAS
Google Scholar
Chen D, et al. Anti-vascular nano agents: a promising approach for cancer treatment. J Mater Chem B. 2020;8(15):2990–3004.
Article
CAS
PubMed
Google Scholar
Khalaf K, et al. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol. 2021;12:656364.
Article
PubMed
PubMed Central
CAS
Google Scholar
Najafi M, Farhood B, Mortezaee K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 2019;120(3):2782–90.
Article
CAS
PubMed
Google Scholar
Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21(4):217–38.
Article
CAS
PubMed
Google Scholar
Kishore C, Bhadra P. Current advancements and future perspectives of immunotherapy in colorectal cancer research. Eur J Pharmacol. 2021;893:173819.
Article
CAS
PubMed
Google Scholar
Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275–92.
Article
CAS
PubMed
Google Scholar
Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156–66.
Article
CAS
PubMed
Google Scholar
Mrozikiewicz-Rakowska B, et al. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Arch Med Sci. 2020;16(1):112–7.
Article
CAS
PubMed
Google Scholar
Beklen H, et al. Drug repositioning for P-glycoprotein mediated co-expression networks in colorectal cancer. Front Oncol. 2020;10:1273.
Article
PubMed
PubMed Central
Google Scholar
Wang B, et al. MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp. Am J Cancer Res. 2018;8(12):2518–27.
CAS
PubMed
PubMed Central
Google Scholar
Jeong KY, et al. Combination antitumor effect of sorafenib via calcium-dependent deactivation of focal adhesion kinase targeting colorectal cancer cells. Molecules. 2020;25(22):5299.
Article
CAS
PubMed Central
Google Scholar
Morris VK, Bekaii-Saab T. Improvements in clinical outcomes for BRAF(V600E) -mutant metastatic colorectal cancer. Clin Cancer Res. 2020;26(17):4435–41.
Article
CAS
PubMed
Google Scholar
Loriot Y, et al. Are RAS mutations predictive markers of resistance to standard chemotherapy? Nat Rev Clin Oncol. 2009;6(9):528–34.
Article
CAS
PubMed
Google Scholar
Goldstein M, Kastan MB. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev Med. 2015;66:129–43.
Article
CAS
PubMed
Google Scholar
Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4(4):307–20.
Article
CAS
PubMed
Google Scholar
Reilly NM, et al. Exploiting DNA repair defects in colorectal cancer. Mol Oncol. 2019;13(4):681–700.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mauri G, et al. The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer. Ann Oncol. 2020;31(9):1135–47.
Article
CAS
PubMed
Google Scholar
McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168(4):613–28.
Article
CAS
PubMed
Google Scholar
Sagaert X, Vanstapel A, Verbeek S. Tumor heterogeneity in colorectal cancer: what do we know so far? Pathobiology. 2018;85(1–2):72–84.
Article
CAS
PubMed
Google Scholar
Nishikawa G, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5. Cell Death Dis. 2019;10(4):264.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mele V, et al. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β. Int J Cancer. 2014;134(11):2583–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ma X, et al. IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133(+) /CD44(+) Colon cancer stem cells. J Cell Physiol. 2021;236(4):3114–28.
Article
CAS
PubMed
Google Scholar
Fontanella R, et al. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion. Cancer Lett. 2016;370(1):100–7.
Article
CAS
PubMed
Google Scholar
Ma X, et al. Mesenchymal stem cells maintain the stemness of colon cancer stem cells via interleukin-8/mitogen-activated protein kinase signaling pathway. Exp Biol Med (Maywood). 2020;245(6):562–75.
Article
CAS
Google Scholar
Lin J-T, et al. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res. 2013;319(14):2216–29.
Article
CAS
PubMed
Google Scholar
Zhang X, et al. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2018;9(2):25.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wu XB, et al. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation. Sci Rep. 2016;6:21420.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li S, et al. Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer. BMC Cancer. 2021;21(1):349.
Article
PubMed
PubMed Central
CAS
Google Scholar
Raz Y, et al. Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer. J Exp Med. 2018;215(12):3075–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ren J, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tan MC, et al. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 2009;182(3):1746–55.
Article
CAS
PubMed
Google Scholar
Monteran L, Erez N. The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment. Front Immunol. 2019;10:1835.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bu L, et al. Functional diversity of cancer-associated fibroblasts in modulating drug resistance. Cancer Sci. 2020;111(10):3468–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Izumi D, et al. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer. Cell Death Dis. 2019;10(4):267.
Article
PubMed
PubMed Central
CAS
Google Scholar
Altadill A, et al. Relationship between metalloprotease-7 and -14 and tissue inhibitor of metalloprotease 1 expression by mucosal stromal cells and colorectal cancer development in inflammatory bowel disease. Biomedicines. 2021;9(5):495.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hartmann N, et al. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Clin Cancer Res. 2014;20(13):3422–33.
Article
CAS
PubMed
Google Scholar
Shevach EM. Garp as a therapeutic target for modulation of T regulatory cell function. Expert Opin Ther Targets. 2017;21(2):191–200.
Article
CAS
PubMed
Google Scholar
Rizzo A, et al. RORγt-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells. Cancer Immunol Res. 2018;6(9):1082–92.
Article
CAS
PubMed
Google Scholar
Ma X, et al. M2-type macrophages induce tregs generation by activating the TGF-β/Smad signalling pathway to promote colorectal cancer development. Onco Targets Ther. 2021;14:5391–402.
Article
PubMed
PubMed Central
Google Scholar
Salem M, et al. GARP dampens cancer immunity by sustaining function and accumulation of regulatory T cells in the colon. Cancer Res. 2019;79(6):1178–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang C, et al. Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice. Gastroenterology. 2018;154(3):675–88.
Article
CAS
PubMed
Google Scholar
Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–81.
Article
CAS
PubMed
Google Scholar
Ning T, et al. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer. Mol Ther. 2021;29(9):2723–36.
Article
CAS
PubMed
Google Scholar
Zhan Y, et al. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization. JCI Insight. 2021;6(16):e148028.
Article
PubMed Central
Google Scholar
Hu G, et al. Tumor-infiltrating CD39(+)γδTregs are novel immunosuppressive T cells in human colorectal cancer. Oncoimmunology. 2017;6(2):e1277305.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ye L, et al. Tumor-infiltrating immune cells act as a marker for prognosis in colorectal cancer. Front Immunol. 2019;10:2368.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yin Y, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23(23):7375–87.
Article
CAS
PubMed
Google Scholar
Del Cornò M, et al. Transcriptome profiles of human visceral adipocytes in obesity and colorectal cancer unravel the effects of body mass index and polyunsaturated fatty acids on genes and biological processes related to tumorigenesis. Front Immunol. 2019;10:265.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ko JH, et al. Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells. J Cell Physiol. 2019;234(10):18249–61.
Article
CAS
PubMed
Google Scholar
Catalán V, et al. Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J Nutr Biochem. 2011;22(7):634–41.
Article
PubMed
CAS
Google Scholar
Peterson JE, et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis. 2012;15(2):265–73.
Article
CAS
PubMed
Google Scholar
Rokavec M, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest. 2014;124(4):1853–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghandadi M, Sahebkar A. Interleukin-6: a critical cytokine in cancer multidrug resistance. Curr Pharm Des. 2016;22(5):518–26.
Article
CAS
PubMed
Google Scholar
Huynh PT, et al. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer. Int J Cancer. 2016;138(8):1971–81.
Article
CAS
PubMed
Google Scholar
Wei C, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019;18(1):64.
Article
PubMed
PubMed Central
Google Scholar
Lv Q, et al. circRNA_101277 influences cisplatin resistance of colorectal cancer cells by modulating the miR-370/IL-6 axis. Genet Res (Camb). 2022;2022:4237327.
Article
CAS
Google Scholar
Wang Y, et al. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett. 2010;295(1):110–23.
Article
CAS
PubMed
Google Scholar
Kim S, et al. IL-4 derived from non-T cells induces basophil- and IL-3-independent Th2 immune responses. Immune Netw. 2013;13(6):249–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hong IS. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types. Exp Mol Med. 2016;48(7):e242.
Article
CAS
PubMed
PubMed Central
Google Scholar
Navarro R, et al. TGF-β-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion. Mol Oncol. 2020;14(10):2609–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Druzhkova I, et al. Expression of EMT-related genes in hybrid E/M colorectal cancer cells determines fibroblast activation and collagen remodeling. Int J Mol Sci. 2020;21(21):8119.
Article
CAS
PubMed Central
Google Scholar
Wu Y, Xu Y. Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer. Cancer Med. 2020;9(13):4743–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu X, et al. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway. Biomed Pharmacother. 2019;114:108708.
Article
CAS
PubMed
Google Scholar
Wang R, et al. B7–H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Cell Death Dis. 2020;11(1):55.
Article
PubMed
PubMed Central
CAS
Google Scholar
Coulson-Thomas VJ, et al. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res. 2011;346(2):223–36.
Article
CAS
PubMed
Google Scholar
Wei B, et al. Human colorectal cancer progression correlates with LOX-induced ECM stiffening. Int J Biol Sci. 2017;13(11):1450–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Afik R, et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix. J Exp Med. 2016;213(11):2315–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kehlet SN, et al. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients. Sci Rep. 2016;6:30599.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seano G, Primo L. Podosomes and invadopodia: tools to breach vascular basement membrane. Cell Cycle. 2015;14(9):1370–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aumailley M, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24(5):326–32.
Article
CAS
PubMed
Google Scholar
Sekiguchi R, Yamada KM. Basement membranes in development and disease. Curr Top Dev Biol. 2018;130:143–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maltseva D, et al. Knockdown of the α5 laminin chain affects differentiation of colorectal cancer cells and their sensitivity to chemotherapy. Biochimie. 2020;174:107–16.
Article
CAS
PubMed
Google Scholar
Zhou B, et al. Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins. Oncogene. 2020;39(7):1527–42.
Article
CAS
PubMed
Google Scholar
Gordon-Weeks A, et al. Tumour-derived laminin α5 (LAMA5) promotes colorectal liver metastasis growth, branching angiogenesis and notch pathway inhibition. Cancers (Basel). 2019;11(5):630.
Article
CAS
Google Scholar
Qin Y, et al. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer. Cancer Lett. 2020;476:161–9.
Article
CAS
PubMed
Google Scholar
Du W, et al. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Drug Deliv. 2021;28(1):920–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mansoori B, et al. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. J Cell Physiol. 2020;235(10):6817–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang G, et al. Colorectal cancer-associated ~ 6 kDa hyaluronan serves as a novel biomarker for cancer progression and metastasis. FEBS J. 2019;286(16):3148–63.
Article
CAS
PubMed
Google Scholar
Kim M, Murakami A, Ohigashi H. Modifying effects of dietary factors on (-)-epigallocatechin-3-gallate-induced pro-matrix metalloproteinase-7 production in HT-29 human colorectal cancer cells. Biosci Biotechnol Biochem. 2007;71(10):2442–50.
Article
CAS
PubMed
Google Scholar
Chen SJ, et al. EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells. Mol Biol Rep. 2012;39(5):5465–71.
Article
CAS
PubMed
Google Scholar
Mythreye K, Blobe GC. Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell Signal. 2009;21(11):1548–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ibrahim SA, et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS ONE. 2013;8(12):e85737.
Article
PubMed
PubMed Central
CAS
Google Scholar
Li J, et al. Hypoxic colorectal cancer-derived extracellular vesicles deliver microRNA-361-3p to facilitate cell proliferation by targeting TRAF3 via the noncanonical NF-κB pathways. Clin Transl Med. 2021;11(3):e349.
CAS
PubMed
PubMed Central
Google Scholar
Watts ER, Walmsley SR. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med. 2019;25(1):33–46.
Article
CAS
PubMed
Google Scholar
Pezzuto A, Carico E. Role of HIF-1 in cancer progression: novel insights. A review. Curr Mol Med. 2018;18(6):343–51.
Article
CAS
PubMed
Google Scholar
Narayanankutty A. PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence. Curr Drug Targets. 2019;20(12):1217–26.
Article
CAS
PubMed
Google Scholar
Wang HG, et al. KLF2 inhibits cell growth via regulating HIF-1α/Notch-1 signal pathway in human colorectal cancer HCT116 cells. Oncol Rep. 2017;38(1):584–90.
Article
CAS
PubMed
Google Scholar
Xu Z, et al. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer. Cell Death Dis. 2018;9(10):974.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, et al. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation. J Exp Clin Cancer Res. 2016;35:29.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zong S, et al. Identification of hypoxia-regulated angiogenic genes in colorectal cancer. Biochem Biophys Res Commun. 2017;493(1):461–7.
Article
CAS
PubMed
Google Scholar
Sui H, et al. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Cancer Lett. 2017;403:86–97.
Article
CAS
PubMed
Google Scholar
Zhang W, et al. HIF-1α promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer. PLoS ONE. 2015;10(6):e0129603.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu C, et al. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. Cancer Sci. 2021;112(10):4198–207.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang Y, et al. Hypoxia enhances activity and malignant behaviors of colorectal cancer cells through the STAT3/MicroRNA-19a/PTEN/PI3K/AKT axis. Anal Cell Pathol (Amst). 2021;2021:4132488.
Google Scholar
Nagaraju GP, et al. Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3. Angiogenesis. 2013;16(4):903–17.
Article
PubMed
Google Scholar
Heimes D, et al. In vivo modulation of angiogenesis and immune response on a collagen matrix via extracorporeal shockwaves. Int J Mol Sci. 2020;21(20):7574.
Article
CAS
PubMed Central
Google Scholar
Rosen LS, Jacobs IA, Burkes RL. Bevacizumab in colorectal cancer: current role in treatment and the potential of biosimilars. Target Oncol. 2017;12(5):599–610.
Article
PubMed
PubMed Central
Google Scholar
Fukuoka S, et al. Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603). J Clin Oncol. 2020;38(18):2053–61.
Article
CAS
PubMed
Google Scholar
Li N, et al. Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles. Pharm Dev Technol. 2020;25(5):556–65.
Article
CAS
PubMed
Google Scholar
Tien J, et al. Interstitial hypertension suppresses escape of human breast tumor cells via convection of interstitial fluid. Cell Mol Bioeng. 2021;14(2):147–59.
Article
CAS
PubMed
Google Scholar
Lunt SJ, et al. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol. 2008;4(6):793–802.
Article
PubMed
Google Scholar
Wang G, et al. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol. 2019;234(10):17023–49.
Article
CAS
PubMed
Google Scholar
Hu PS, et al. VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduct Target Ther. 2020;5(1):183.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomed. 2008;3(2):133–49.
Article
Google Scholar
Swetledge S, et al. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. J Nanobiotechnol. 2021;19(1):10.
Article
CAS
Google Scholar
Verma P, et al. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomater Sci. 2021;9(5):1481–502.
Article
CAS
PubMed
Google Scholar
Thurner GC, Haybaeck J, Debbage P. Targeting drug delivery in the elderly: are nanoparticles an option for treating osteoporosis? Int J Mol Sci. 2021;22(16):8932.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kulkarni PV, et al. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer’s disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(1):35–47.
Article
CAS
PubMed
Google Scholar
Alkaff SA, et al. Nanocarriers for stroke therapy: advances and obstacles in translating animal studies. Int J Nanomed. 2020;15:445–64.
Article
CAS
Google Scholar
Taurin S, Nehoff H, Greish K. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? J Control Release. 2012;164(3):265–75.
Article
CAS
PubMed
Google Scholar
Chen Y, et al. Hydrogen peroxide and hypochlorite responsive fluorescent nanoprobes for sensitive cancer cell imaging. Biosensors (Basel). 2022;12(2):111.
Article
CAS
Google Scholar
Wang J, Li Y, Nie G. Multifunctional biomolecule nanostructures for cancer therapy. Nat Rev Mater. 2021;6(9):766–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mundekkad D, Cho WC. Nanoparticles in clinical translation for cancer therapy. Int J Mol Sci. 2022;23(3):1685.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baek S, et al. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles. Nanoscale. 2015;7(34):14191–216.
Article
CAS
PubMed
Google Scholar
Govindarasu M, et al. Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin. Biotechnol Appl Biochem. 2022. https://doi.org/10.1002/bab.2290.
Article
PubMed
Google Scholar
Sun T, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53(46):12320–64.
CAS
PubMed
Google Scholar
Ana Luiza CdSLO, et al. Effect of oxaliplatin-loaded poly (d, l-lactide-co-glycolic acid) (PLGA) nanoparticles combined with retinoic acid and cholesterol on apoptosis, drug resistance, and metastasis factors of colorectal cancer. Pharmaceutics. 2020;12(2):193.
Article
CAS
Google Scholar
Ghasemi Toudeshkchouei M, Zahedi P, Shavandi A. Microfluidic-assisted preparation of 5-fluorouracil-loaded PLGA nanoparticles as a potential system for colorectal cancer therapy. Materials (Basel). 2020;13(7):1483.
Article
CAS
Google Scholar
Xiao B, et al. Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. J Mater Chem B. 2015;3(39):7724–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li L, et al. Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells. Int J Pharm. 2012;438(1–2):1–10.
Article
CAS
PubMed
Google Scholar
Shi G, et al. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer. Adv Clin Exp Med. 2019;28(4):479–87.
Article
PubMed
Google Scholar
Liang G, et al. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model. Gene Ther. 2016;23(12):829–38.
Article
CAS
PubMed
Google Scholar
Javan B, Atyabi F, Shahbazi M. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy. Life Sci. 2018;202:140–51.
Article
CAS
PubMed
Google Scholar
Zhu YJ, Chen F. pH-responsive drug-delivery systems. Chem Asian J. 2015;10(2):284–305.
Article
CAS
PubMed
Google Scholar
Sani NS, et al. A comparison of the anti-cancer effects of free and PLGA-PAA encapsulated hydroxytyrosol on the HT-29 colorectal cancer cell line. Anticancer Agents Med Chem. 2022;22(2):390–4.
Article
PubMed
Google Scholar
Lee KD, et al. Cisplatin-incorporated nanoparticles of poly(acrylic acid-co-methyl methacrylate) copolymer. Int J Nanomed. 2013;8:2835–45.
Google Scholar
Zhang X, et al. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment. Biomater Sci. 2020;8(7):1885–96.
Article
CAS
PubMed
Google Scholar
Feng ST, et al. pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells. PLoS ONE. 2014;9(6):e100732.
Article
PubMed
PubMed Central
Google Scholar
Jiang XJ, et al. pH- and thiol-responsive BODIPY-based photosensitizers for targeted photodynamic therapy. Chemistry. 2016;22(24):8273–81.
Article
CAS
PubMed
Google Scholar
Brunato S, et al. PEG-polyaminoacid based micelles for controlled release of doxorubicin: rational design, safety and efficacy study. J Control Release. 2021;335:21–37.
Article
CAS
PubMed
Google Scholar
Tasdogan A, Ubellacker JM, Morrison SJ. Redox regulation in cancer cells during metastasis. Cancer Discov. 2021;11(11):2682–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li D, et al. Redox-responsive self-assembled nanoparticles for cancer therapy. Adv Healthc Mater. 2020;9(20):e2000605.
Article
PubMed
CAS
Google Scholar
Xiong Y, et al. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013–41.
Article
CAS
PubMed
Google Scholar
Sauraj, et al. Redox-sensitive nanoparticles based on xylan-lipoic acid conjugate for tumor targeted drug delivery of niclosamide in cancer therapy. Carbohydr Res. 2021;499:108222.
Article
CAS
PubMed
Google Scholar
Wang J, et al. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater. 2013;25(27):3670–6.
Article
CAS
PubMed
Google Scholar
Lee HL, et al. Redox- and pH-responsive nanoparticles release piperlongumine in a stimuli-sensitive manner to inhibit pulmonary metastasis of colorectal carcinoma cells. J Pharm Sci. 2018;107(10):2702–12.
Article
CAS
PubMed
Google Scholar
Durán-Lobato M, et al. Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization. Sci Rep. 2022;12(1):1297.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wei Y, et al. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo. J Control Release. 2020;319:407–15.
Article
CAS
PubMed
Google Scholar
Rosch JG, et al. Formulation of folate-modified raltitrexed-loaded nanoparticles for colorectal cancer theranostics. Pharmaceutics. 2020;12(2):133.
Article
CAS
PubMed Central
Google Scholar
Oliveira A, et al. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer. Mater Sci Eng C Mater Biol Appl. 2021;120:111678.
Article
CAS
PubMed
Google Scholar
Feng CL, et al. Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer. Drug Deliv. 2017;24(1):1537–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhong Y, et al. Co-administration of iRGD enhances tumor-targeted delivery and anti-tumor effects of paclitaxel-loaded PLGA nanoparticles for colorectal cancer treatment. Int J Nanomed. 2019;14:8543–60.
Article
CAS
Google Scholar
Zhang Z, et al. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomed. 2018;13:4961–75.
Article
CAS
Google Scholar
Wen X, et al. Application of taxol nanomicelles with Lyp-1 target in targeted 805–813 therapy of colon cancer. J Nanosci Nanotechnol. 2021;21(2):805–13.
Article
CAS
PubMed
Google Scholar
Noh I, et al. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy. Biomaterials. 2021;275:120926.
Article
CAS
PubMed
Google Scholar
Liu G, et al. Doxorubicin-loaded tumor-targeting peptide-decorated polypeptide nanoparticles for treating primary orthotopic colon cancer. Front Pharmacol. 2021;12:744811.
Article
CAS
PubMed
PubMed Central
Google Scholar
He F, et al. Aptamer-based targeted drug delivery systems: current potential and challenges. Curr Med Chem. 2020;27(13):2189–219.
Article
CAS
PubMed
Google Scholar
Bates PJ, et al. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms. Biochim Biophys Acta Gen Subj. 2017;1861(5 Pt B):1414–28.
Article
CAS
PubMed
Google Scholar
Yu Z, et al. Targeted treatment of colon cancer with aptamer-guided albumin nanoparticles loaded with docetaxel. Int J Nanomed. 2020;15:6737–48.
Article
CAS
Google Scholar
Mohtar MA, et al. Revisiting the roles of pro-metastatic EpCAM in cancer. Biomolecules. 2020;10(2):255.
Article
PubMed Central
CAS
Google Scholar
Zhang Y, et al. PEG-poly(amino acid)s/EpCAM aptamer multifunctional nanoparticles arrest the growth and metastasis of colorectal cancer. Biomater Sci. 2021;9(10):3705–17.
Article
CAS
PubMed
Google Scholar
Zhao Y, et al. EpCAM aptamer-functionalized cationic liposome-based nanoparticles loaded with miR-139-5p for targeted therapy in colorectal cancer. Mol Pharm. 2019;16(11):4696–710.
Article
CAS
PubMed
Google Scholar
Arslan FB, Ozturk Atar K, Calis S. Antibody-mediated drug delivery. Int J Pharm. 2021;596:120268.
Article
CAS
PubMed
Google Scholar
Liszbinski RB, et al. Anti-EGFR-coated gold nanoparticles in vitro carry 5-fluorouracil to colorectal cancer cells. Materials (Basel). 2020;13(2):375.
Article
CAS
Google Scholar
Lin CY, et al. Panitumumab-conjugated and platinum-cored pH-sensitive apoferritin nanocages for colorectal cancer-targeted therapy. ACS Appl Mater Interfaces. 2018;10(7):6096–106.
Article
CAS
PubMed
Google Scholar
Mohd-Zahid MH, et al. Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting. RSC Adv. 2021;11(26):16131–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pereira I, et al. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells. Int J Pharm. 2018;549(1):397–403.
Article
CAS
PubMed
Google Scholar
Chang N, et al. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer. Drug Deliv. 2020;27(1):1073–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Juang V, et al. pH-responsive PEG-shedding and targeting peptide-modified nanoparticles for dual-delivery of irinotecan and microRNA to enhance tumor-specific therapy. Small. 2019;15(49):e1903296.
Article
PubMed
CAS
Google Scholar
Shi Y, et al. Application of the tumor site recognizable and dual-responsive nanoparticles for combinational treatment of the drug-resistant colorectal cancer. Pharm Res. 2020;37(4):72.
Article
CAS
PubMed
Google Scholar
Li Y, et al. Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer. Cancer Biol Med. 2020;17(2):307–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
El-Boubbou K. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery. Nanomedicine (Lond). 2018;13(8):929–52.
Article
CAS
Google Scholar
Nosrati R, et al. Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma. Sci Rep. 2021;11(1):13065.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kwiatkowski S, et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–107.
Article
CAS
PubMed
Google Scholar
Sun S, et al. Ce6-modified carbon dots for multimodal-imaging-guided and single-NIR-laser-triggered photothermal/photodynamic synergistic cancer therapy by reduced irradiation power. ACS Appl Mater Interfaces. 2019;11(6):5791–803.
Article
CAS
PubMed
Google Scholar
Chu WY, et al. pH-responsive nanophotosensitizer for an enhanced photodynamic therapy of colorectal cancer overexpressing EGFR. Mol Pharm. 2018;15(4):1432–44.
Article
CAS
PubMed
Google Scholar
Huo S, et al. Mechano-nanoswitches for ultrasound-controlled drug activation. Adv Sci (Weinh). 2022;9(12):e2104696.
Article
CAS
Google Scholar
Yan L, et al. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro. Int J Biol Macromol. 2020;162:1303–10.
Article
CAS
PubMed
Google Scholar
Hasani-Sadrabadi MM, et al. Microfluidic manipulation of core/shell nanoparticles for oral delivery of chemotherapeutics: a new treatment approach for colorectal cancer. Adv Mater. 2016;28(21):4134–41.
Article
CAS
PubMed
Google Scholar
Li X, et al. Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots. J Mater Chem B. 2020;8(11):2307–20.
Article
CAS
PubMed
Google Scholar
Bak A, Ashford M, Brayden DJ. Local delivery of macromolecules to treat diseases associated with the colon. Adv Drug Deliv Rev. 2018;136–137:2–27.
Article
PubMed
CAS
Google Scholar
Wang Y, et al. Microencapsulation of nanoparticles with enhanced drug loading for pH-sensitive oral drug delivery for the treatment of colon cancer. J Appl Polym Sci. 2013;129(2):714–20.
Article
CAS
Google Scholar
Li Y, et al. Nanodiamond-based multifunctional platform for oral chemo-photothermal combinational therapy of orthotopic colon cancer. Pharmacol Res. 2022;176:106080.
Article
CAS
PubMed
Google Scholar
Hou Y, et al. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer. Biomaterials. 2022;283:121440.
Article
CAS
PubMed
Google Scholar
Landesman-Milo D, et al. Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells. Cancer Lett. 2013;334(2):221–7.
Article
CAS
PubMed
Google Scholar
Xin Y, et al. Nano-based delivery of RNAi in cancer therapy. Mol Cancer. 2017;16(1):134.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim R, et al. Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma. Cancer. 2004;101(10):2177–86.
Article
CAS
PubMed
Google Scholar
Ray L. Synergistic anticancer activity by co-delivered nanosized dual therapeutic agents and siRNA in colon cancer. J Drug Deliv Sci Technol. 2020;55:101351.
Article
CAS
Google Scholar
Bäumer S, et al. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer. Clin Cancer Res. 2015;21(6):1383–94.
Article
PubMed
CAS
Google Scholar
Yang S, et al. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity. Biomaterials. 2021;272: 120791.
Article
CAS
PubMed
Google Scholar
Klippstein R, et al. Passively targeted curcumin-loaded PEGylated PLGA nanocapsules for colon cancer therapy in vivo. Small. 2015;11(36):4704–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dai J, et al. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed Engl. 2011;50(40):9404–8.
Article
CAS
PubMed
Google Scholar